相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin
Ye Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
Dennis Shin-Shian Hsu et al.
CLINICAL CANCER RESEARCH (2010)
Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase
Yannick Auclair et al.
DNA REPAIR (2010)
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Trudy G. Oliver et al.
GENES & DEVELOPMENT (2010)
DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy
Kai-yuan Teng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Polymerase η mRNA Expression Predicts Survival of Non - Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Paolo Ceppi et al.
CLINICAL CANCER RESEARCH (2009)
Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals
Sigal Shachar et al.
EMBO JOURNAL (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
BRCA1 and implications for response to chemotherapy in ovarian cancer
Jennifer E. Quinn et al.
GYNECOLOGIC ONCOLOGY (2009)
A Backup Role of DNA Polymerase κ in Ig Gene Hypermutation Only Takes Place in the Complete Absence of DNA Polymerase η
Ahmad Faili et al.
JOURNAL OF IMMUNOLOGY (2009)
Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival
Jill M. Wagner et al.
MOLECULAR PHARMACOLOGY (2009)
APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
Dong Wang et al.
LUNG CANCER (2009)
Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
Koichi Azuma et al.
LUNG CANCER (2009)
Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy
Anacelia Mendes Fernandes et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)
Human DNA polymerase η activity and translocation is regulated by phosphorylation
Yih-wen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines
Kyunghee Burkitt et al.
CANCER LETTERS (2007)
Pol η is required for DNA replication during nucleotide deprivation by hydroxyurea
S. de Feraudy et al.
ONCOGENE (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions
Steven R. Bartz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A novel role of DNA polymerase η in modulating cellular sensitivity to chemotherapeutic agents
YW Chen et al.
MOLECULAR CANCER RESEARCH (2006)
ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy
FM Wachters et al.
LUNG CANCER (2005)
A role for polymerase η in the cellular tolerance to cisplatin-induced damage
MR Albertella et al.
CANCER RESEARCH (2005)
Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA
F Moreno-Herrero et al.
NATURE (2005)
Novel markers for poor prognosis in head and neck cancer
D Chin et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Down-regulation of DNA polymerases κ, η, ι, and ξ in human lung, stomach, and colorectal cancers
QR Pan et al.
CANCER LETTERS (2005)
Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases β and η in vitro
E Bassett et al.
BIOCHEMISTRY (2003)
The role of polymerase η in somatic Hypermutation determined by analysis of mutations in a patient with xeroderma pigmentosum variant
S Yavuz et al.
JOURNAL OF IMMUNOLOGY (2002)
Translesion synthesis by human DNA polymerase η across thymine glycol lesions
R Kusumoto et al.
BIOCHEMISTRY (2002)
DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes
XM Zeng et al.
NATURE IMMUNOLOGY (2001)
Translesion DNA synthesis catalyzed by human pol η and pol κ across 1,N6-ethenodeoxyadenosine
RL Levine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Error-prone lesion bypass by human DNA polymerase η
YB Zhang et al.
NUCLEIC ACIDS RESEARCH (2000)
Replication past O6-methylguanine by yeast and human DNA polymerase η
L Haracska et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase η
L Haracska et al.
NATURE GENETICS (2000)
Low fidelity DNA synthesis by human DNA polymerase-η
T Matsuda et al.
NATURE (2000)
Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η
A Vaisman et al.
BIOCHEMISTRY (2000)
Specificity of DNA lesion bypass by the yeast DNA polymerase η
FH Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
